Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Melzer

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatmentJulia Schubert, Dirk Brämer, Hagen B Huttner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degenerationRamona Miske, Catharina C Gross, Madeleine Scharf, et al.
Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Brain, Behavior, and Immunity|May 12, 2026
Associations between CRP-related DNA methylation, stress exposure, and depression severity in a longitudinal clinical cohortPaula L Usemann, Friederike S David, Luca Sagcob, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Annals of Neurology|March 25, 2018
Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitisStefanie H Mueller, Anna Färber, Harald Prüss, et al.
Journal of Affective Disorders|February 19, 2026
Genetic predisposition to inflammation and psychopathology: A transdiagnostic network analysisPaula Usemann, Friederike S David, Katharina Brosch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 29, 2021
Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR EncephalitisAnja K Tietz, Klemens Angstwurm, Tobias Baumgartner, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Neurology(R) Neuroimmunology & Neuroinflammation|December 21, 2018
Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatmentJulia Schubert, Dirk Brämer, Hagen B Huttner, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 14, 2016
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degenerationRamona Miske, Catharina C Gross, Madeleine Scharf, et al.
Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.
Frontiers in Immunology|December 30, 2024
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitisSarah Jesse, Marie Riemann, Hauke Schneider, et al.
Brain, Behavior, and Immunity|May 12, 2026
Associations between CRP-related DNA methylation, stress exposure, and depression severity in a longitudinal clinical cohortPaula L Usemann, Friederike S David, Luca Sagcob, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 23, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumabSaskia Räuber, Melanie Korsen, Niklas Huntemann, et al.
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Annals of Neurology|March 25, 2018
Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitisStefanie H Mueller, Anna Färber, Harald Prüss, et al.
Journal of Affective Disorders|February 19, 2026
Genetic predisposition to inflammation and psychopathology: A transdiagnostic network analysisPaula Usemann, Friederike S David, Katharina Brosch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 29, 2021
Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR EncephalitisAnja K Tietz, Klemens Angstwurm, Tobias Baumgartner, et al.
Pageof 15